Online ADHD Medication Startup Ahead Is Shutting Down
This article is for subscribers only.
Ahead, an online provider of ADHD treatment, is shutting down, its top investor said Thursday.
The company will immediately stop taking new patients and will continue to provide current patients with care through June 24, said Sid Viswanathan, the chief executive officer of Ahead backer Truepill. As Truepill has shifted its focus to serving corporate and business customers, “we made the difficult decision to no longer invest in Ahead,” Viswanathan wrote in an email to Bloomberg.